567 related articles for article (PubMed ID: 35692405)
1. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy.
Yang J; Liu Z
Front Endocrinol (Lausanne); 2022; 13():816400. PubMed ID: 35692405
[TBL] [Abstract][Full Text] [Related]
2. Integration of Metabolomics and Proteomics in Exploring the Endothelial Dysfunction Mechanism Induced by Serum Exosomes From Diabetic Retinopathy and Diabetic Nephropathy Patients.
Yang J; Liu D; Liu Z
Front Endocrinol (Lausanne); 2022; 13():830466. PubMed ID: 35399949
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous microangiopathy in patients with type 2 diabetes: Impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy.
Sugimoto K; Murakami H; Deguchi T; Arimura A; Daimon M; Suzuki S; Shimbo T; Yagihashi S
J Diabetes Investig; 2019 Sep; 10(5):1318-1331. PubMed ID: 30719863
[TBL] [Abstract][Full Text] [Related]
4. Microvascular cells: A special focus on heterogeneity of pericytes in diabetes associated complications.
Rajendran S; Seetharaman S; Dharmarajan A; Kuppan K
Int J Biochem Cell Biol; 2021 May; 134():105971. PubMed ID: 33775914
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Pathophysiological Mechanisms of Diabetic Retinopathy in Relation to Adhesion Molecules.
Joy SS; Siddiqui K
Curr Diabetes Rev; 2019; 15(5):363-371. PubMed ID: 30332969
[TBL] [Abstract][Full Text] [Related]
6. SETD8 cooperates with MZF1 to participate in hyperglycemia-induced endothelial inflammation via elevation of WNT5A levels in diabetic nephropathy.
Wang F; Hou W; Li X; Lu L; Huang T; Zhu M; Miao C
Cell Mol Biol Lett; 2022 Mar; 27(1):30. PubMed ID: 35350980
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
9. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
Kaabi YA
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
[TBL] [Abstract][Full Text] [Related]
10. The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy-A Short Review.
Gomułka K; Ruta M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674535
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor FOXP1 mediates vascular endothelial dysfunction in diabetic retinopathy.
Zhou Y; Xuan Y; Liu Y; Zheng J; Jiang X; Zhang Y; Zhao J; Liu Y; An M
Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3857-3867. PubMed ID: 35695913
[TBL] [Abstract][Full Text] [Related]
12. Implications of treatment that target protective mechanisms against diabetic nephropathy.
Mima A; Qi W; King GL
Semin Nephrol; 2012 Sep; 32(5):471-8. PubMed ID: 23062988
[TBL] [Abstract][Full Text] [Related]
13. Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy.
Kaur G; Harris NR
Am J Physiol Cell Physiol; 2023 May; 324(5):C1061-C1077. PubMed ID: 36939202
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia induced early growth response-1 regulates vascular dysfunction in human retinal endothelial cells.
Karthikkeyan G; Nareshkumar RN; Aberami S; Sulochana KN; Vedantham S; Coral K
Microvasc Res; 2018 May; 117():37-43. PubMed ID: 29307595
[TBL] [Abstract][Full Text] [Related]
15. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
[TBL] [Abstract][Full Text] [Related]
16. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
Gendeleka GF
Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158
[No Abstract] [Full Text] [Related]
17. Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy.
Li L; Dai Y; Ke D; Liu J; Chen P; Wei D; Wang T; Teng Y; Yuan X; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1215292. PubMed ID: 37600716
[TBL] [Abstract][Full Text] [Related]
18. Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents.
Dennis MD; Kimball SR; Fort PE; Jefferson LS
J Biol Chem; 2015 Feb; 290(6):3865-74. PubMed ID: 25548280
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia Induces Neutrophil Extracellular Traps Formation Through an NADPH Oxidase-Dependent Pathway in Diabetic Retinopathy.
Wang L; Zhou X; Yin Y; Mai Y; Wang D; Zhang X
Front Immunol; 2018; 9():3076. PubMed ID: 30671057
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the crucial role of intercellular adhesion molecule-1 in secondary diabetic complications.
Kaur P; Dahiya R; Nandave M; Sharma K; Goyal RK
Cell Biochem Funct; 2024 Jun; 42(4):e4037. PubMed ID: 38736204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
